Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Determining the Impact of a Cancer Diagnosis on Diabetes Management

A Systematic Literature Review

Pinheiro, Laura C. PhD, MPH*; Kaur, Harveen MPH*; Nilo, Daniela BA*; Safford, Monika M. MD*; DeRosa, Antonio P. MS, MLIS, AHIP; Kern, Lisa M. MD, MPH*

American Journal of Clinical Oncology: November 2019 - Volume 42 - Issue 11 - p 870–883
doi: 10.1097/COC.0000000000000612
Review Article
Buy
SDC

Objectives: Cancer patients with comorbid diabetes have a 50% increased risk of all-cause mortality compared with cancer patients without diabetes. Less attention to diabetes management (glucose control, medication adherence, and diabetes self-management behaviors) during active cancer treatment is hypothesized as an explanation for worse outcomes among diabetic cancer patients. The objective of this systematic review is to determine and quantify how a cancer diagnosis impacts diabetes management.

Methods: Quantitative and qualitative studies evaluating diabetes management among patients were identified by searching 4 databases: MEDLINE, EMBASE, The Cochrane Library, and Web of Science. Two independent reviewers extracted data and summarized results from eligible studies. Study quality was formally assessed.

Results: Thirty-six studies met all inclusion criteria. We observed heterogeneity across studies in terms of study design, sample size, cancer site, type of diabetes management evaluated, and quality. Numerous articles discussed that overall, glucose control, medication adherence, and diabetes self-management behaviors declined following a cancer diagnosis. However, findings were inconsistent across studies.

Conclusions: Although the effects of a cancer diagnosis on diabetes management are mixed, when results across studies were synthesized together, diabetes management appeared to generally decline after a cancer diagnosis. Declines in diabetes management seem to be primarily due to shifts in the priority of care from diabetes management to cancer. A next critical step in this line of work is to identify patient and provider level predictors of better or worse diabetes management to design and test interventions aimed at improving effective diabetes management for cancer patients.

*Department of Medicine, Division of General Internal Medicine

Samuel J. Wood Library & C.V. Starr Biomedical Information Center, Weill Cornell Medicine, New York, NY

Supported by Weill Cornell Medicine’s Department of Medicine Career Development Award.

The authors declare no conflicts of interest.

Reprints: Laura C. Pinheiro, PhD, MPH, Department of Medicine, Division of General Internal Medicine, Weill Cornell Medicine, 3rd Floor (LH359), 420 East 70th Street, New York, NY 10021. E-mail: lcp2003@med.cornell.edu.

Online date: October 4, 2019

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.